SynthesisMedicine2017

Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes: A meta-analysis of randomized controlled trials.

Binjie Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.